Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018

Date: January 31, 2013
Pages: 81
Price:
US$ 2,500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I9E053135DDEN
Leaflet:

Download PDF Leaflet

Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018

Summary

“Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope
  • Market size and company share data for Drug Delivery Devices market categories – Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Ireland Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Baxter International Inc., B. Braun Melsungen AG, Hospira, Inc. and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Ireland Drug Delivery Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 DRUG DELIVERY DEVICES IN IRELAND

3.1 Drug Delivery Devices, Ireland, Overall Revenue ($m), USD Constant, 2004-2018
3.2 Drug Delivery Devices, Ireland, Company Share (2010-2011)

4 CENTRAL VENOUS CATHETERS IN IRELAND

4.1 Central Venous Catheters Overall Revenue, (2004-2018)
4.2 Central Venous Catheters Overall Volume (2004-2018)
4.3 Central Venous Catheters Average Price (2004-2018)
4.4 Central Venous Catheters Distribution Share (2010-2011)
4.5 Central Venous Catheters, Ireland, Company Share (2010-2011)

5 INFUSION SYSTEMS IN IRELAND

5.1 Infusion Systems Overall Revenue, (2004-2018)
  5.1.1 Syringe Pumps, Revenue (2004-2018)
  5.1.2 Ambulatory Infusion Pumps, Revenue (2004-2018)
5.2 Infusion Systems Overall Volume (2004-2018)
  5.2.1 Syringe Pumps, Volume (2004-2018)
  5.2.2 Ambulatory Infusion Pumps, Volume (2004-2018)
5.3 Infusion Systems Average Price (2004-2018)
5.4 Infusion Systems Distribution Share (2010-2011)
5.5 Infusion Systems, Ireland, Company Share (2010-2011)

6 METERED DOSE INHALER DEVICES IN IRELAND

6.1 Metered Dose Inhaler Devices Overall Revenue, (2004-2018)
6.2 Metered Dose Inhaler Devices Overall Volume (2004-2018)
6.3 Metered Dose Inhaler Devices Average Price (2004-2018)
6.4 Metered Dose Inhaler Devices Distribution Share (2010-2011)
6.5 Metered Dose Inhaler Devices, Ireland, Company Share (2010-2011)

7 NEEDLE FREE INJECTIONS IN IRELAND

7.1 Needle Free Injections Overall Revenue, (2004-2018)
7.2 Needle Free Injections Overall Volume (2004-2018)
7.3 Needle Free Injections Average Price (2004-2018)
7.4 Needle Free Injections Distribution Share (2010-2011)
7.5 Needle Free Injections, Ireland, Company Share (2010-2011)

8 OVERVIEW OF KEY COMPANIES IN IRELAND DRUG DELIVERY DEVICES MARKET

8.1 GlaxoSmithKline plc
  8.1.1 Company Overview
8.2 AstraZeneca PLC
  8.2.1 Company Overview
8.3 Boehringer Ingelheim GmbH
  8.3.1 Company Overview
8.4 3M Health Care Ltd.
  8.4.1 Company Overview
8.5 Baxter International Inc.
  8.5.1 Company Overview
8.6 Hospira, Inc.
  8.6.1 Company Overview
8.7 B. Braun Melsungen AG
  8.7.1 Company Overview
8.8 Medtronic, Inc.
  8.8.1 Company Overview
8.9 Fresenius Kabi AG
  8.9.1 Company Overview
8.10 Smiths Medical
  8.10.1 Company Overview
8.11 Teleflex Incorporated
  8.11.1 Company Overview
8.12 Terumo Corporation
  8.12.1 Company Overview
8.13 Consort Medical plc
  8.13.1 Company Overview
8.14 INJEX - Equidyne Systems
  8.14.1 Company Overview
8.15 Edwards Lifesciences Corporation
  8.15.1 Company Overview
8.16 CareFusion Corporation
  8.16.1 Company Overview
8.17 Sunovion Pharmaceuticals Inc.
  8.17.1 Company Overview
8.18 Becton, Dickinson and Company
  8.18.1 Company Overview
8.19 C. R. Bard, Inc.
  8.19.1 Company Overview
8.20 Cook Medical Incorporated
  8.20.1 Company Overview
8.21 Bioject Medical Technologies Inc.
  8.21.1 Company Overview
8.22 Antares Pharma, Inc.
  8.22.1 Company Overview

9 APPENDIX

9.1 Global Markets Direct Research Methodology
9.2 Definitions of Markets Covered in the Report
  9.2.1 Drug Delivery Devices
9.3 Secondary Research
9.4 Primary Research
9.5 Models
9.6 Forecasts
9.7 Expert Panel Validation
9.8 Currency Conversion
9.9 Contact Us
9.10 Disclaimer

LIST OF TABLES

Table 1: Drug Delivery Devices, Ireland, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Drug Delivery Devices, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 3: Drug Delivery Devices, Ireland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 4: Drug Delivery Devices, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 5: Central Venous Catheters, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 6: Central Venous Catheters, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 7: Central Venous Catheters, Ireland, Volume (Units) by Segment, Historic, 2004-2011
Table 8: Central Venous Catheters, Ireland, Volume (Units) by Segment, Forecast, 2011-2018
Table 9: Central Venous Catheters, Ireland, Average Price ($), Historic, 2004-2011
Table 10: Central Venous Catheters, Ireland, Average Price ($), Forecast, 2011-2018
Table 11: Central Venous Catheters, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 12: Central Venous Catheters, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Infusion Systems, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 14: Infusion Systems, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 15: Syringe Pumps, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 16: Syringe Pumps, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 17: Ambulatory Infusion Pumps, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 18: Ambulatory Infusion Pumps, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 19: Infusion Systems, Ireland, Volume (Units) by Segment, Historic, 2004-2011
Table 20: Infusion Systems, Ireland, Volume (Units) by Segment, Forecast, 2011-2018
Table 21: Syringe Pumps, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 22: Syringe Pumps, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 23: Ambulatory Infusion Pumps, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 24: Ambulatory Infusion Pumps, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 25: Infusion Systems, Ireland, Average Price ($), Historic, 2004-2011
Table 26: Infusion Systems, Ireland, Average Price ($), Forecast, 2011-2018
Table 27: Infusion Systems, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 28: Infusion Systems, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Metered Dose Inhaler Devices, Ireland, Revenue ($m) USD Constant, Historic, 2004-2011
Table 30: Metered Dose Inhaler Devices, Ireland, Revenue ($m) USD Constant, Forecast, 2011-2018
Table 31: Metered Dose Inhaler Devices, Ireland, Volume (Units), Historic, 2004-2011
Table 32: Metered Dose Inhaler Devices, Ireland, Volume (Units), Forecast, 2011-2018
Table 33: Metered Dose Inhaler Devices, Ireland, Average Price ($), Historic, 2004-2011
Table 34: Metered Dose Inhaler Devices, Ireland, Average Price ($), Forecast, 2011-2018
Table 35: Metered Dose Inhaler Devices, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Metered Dose Inhaler Devices, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Needle Free Injections, Ireland, Revenue ($m) USD Constant, Historic, 2004-2011
Table 38: Needle Free Injections, Ireland, Revenue ($m) USD Constant, Forecast, 2011-2018
Table 39: Needle Free Injections, Ireland, Volume (Units), Historic, 2004-2011
Table 40: Needle Free Injections, Ireland, Volume (Units), Forecast, 2011-2018
Table 41: Needle Free Injections, Ireland, Average Price ($), Historic, 2004-2011
Table 42: Needle Free Injections, Ireland, Average Price ($), Forecast, 2011-2018
Table 43: Needle Free Injections, Ireland, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 44: Needle Free Injections, Ireland, Company Share by Revenue ($m), USD Constant, 2010-2011

LIST OF FIGURES

Figure 1: Drug Delivery Devices, Ireland, Overall Revenue ($m), USD Constant, 2004-2018
Figure 2: Drug Delivery Devices, Ireland, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 3: Drug Delivery Devices, Ireland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 4: Drug Delivery Devices, Ireland, Company Share (%), 2011
Figure 5: Central Venous Catheters, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 6: Central Venous Catheters, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 7: Central Venous Catheters, Ireland, Volume (Units) by Segment, Historic, 2004-2011
Figure 8: Central Venous Catheters, Ireland, Volume (Units) by Segment, Forecast, 2011-2018
Figure 9: Central Venous Catheters, Ireland, Company Share (%), 2011
Figure 10: Infusion Systems, Ireland, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 11: Infusion Systems, Ireland, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 12: Syringe Pumps, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 13: Syringe Pumps, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 14: Ambulatory Infusion Pumps, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 15: Ambulatory Infusion Pumps, Ireland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 16: Infusion Systems, Ireland, Volume (Units) by Segment, Historic, 2004-2011
Figure 17: Infusion Systems, Ireland, Volume (Units) by Segment, Forecast, 2011-2018
Figure 18: Syringe Pumps, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 19: Syringe Pumps, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 20: Ambulatory Infusion Pumps, Ireland, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 21: Ambulatory Infusion Pumps, Ireland, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 22: Infusion Systems, Ireland, Company Share (%), 2011
Figure 23: Metered Dose Inhaler Devices, Ireland, Revenue ($m) USD Constant, Historic, 2004-2011
Figure 24: Metered Dose Inhaler Devices, Ireland, Revenue ($m) USD Constant, Forecast, 2011-2018
Figure 25: Metered Dose Inhaler Devices, Ireland, Volume (Units), Historic, 2004-2011
Figure 26: Metered Dose Inhaler Devices, Ireland, Volume (Units), Forecast, 2011-2018
Figure 27: Metered Dose Inhaler Devices, Ireland, Company Share (%), 2011
Figure 28: Needle Free Injections, Ireland, Revenue ($m) USD Constant, Historic, 2004-2011
Figure 29: Needle Free Injections, Ireland, Revenue ($m) USD Constant, Forecast, 2011-2018
Figure 30: Needle Free Injections, Ireland, Volume (Units), Historic, 2004-2011
Figure 31: Needle Free Injections, Ireland, Volume (Units), Forecast, 2011-2018
Figure 32: Needle Free Injections, Ireland, Company Share (%), 2011
Figure 33: Global Markets Direct Methodology

COMPANIES MENTIONED

GlaxoSmithKline plc
AstraZeneca PLC
Boehringer Ingelheim GmbH
3M Health Care Ltd.
Baxter International Inc.
Hospira, Inc.
B. Braun Melsungen AG
Medtronic, Inc.
Fresenius Kabi AG
Smiths Medical
Teleflex Incorporated
Terumo Corporation
Consort Medical plc
INJEX - Equidyne Systems
Edwards Lifesciences Corporation
CareFusion Corporation
Sunovion Pharmaceuticals Inc.
Becton, Dickinson and Company
C. R. Bard, Inc.
Cook Medical Incorporated
Bioject Medical Technologies Inc.
Antares Pharma, Inc.

Ask Your Question

Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: